Annual Scientific Sessions of American Heart Association
November 11, 2003 Orlando, FL
|
|
|
||
| The
1st Vulnerable Patient Satellite Symposium Annual Scientific Sessions of American Heart Association November 11, 2003 Orlando, FL |
|||
|
|
|||||||||||||||
| Thanks to our Sponsors: Amersham Health, diaDexus, and CV Therapeutics. | |||||||||||||||
|
The VP Symposium To Go! (a quick review in bullet points.) PDF MS-DOC |
|||||||||||||||
 |
Morteza Naghavi, M.D. AEHA, Houston, TX, USA | ||||||||||||||
| "From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Stratification Strategies" | |||||||||||||||
| View the Video Presentation -
View PowerPoint
Slides - Bullet Points >>
PDF
MS-DOC The AEHA Mission proposed by Dr Naghavi. |
|||||||||||||||
 |
Valentin Fuster, M.D., Ph.D. – Mount Sinai Hospital, New York, USA | ||||||||||||||
| Topic: MRI / CT for Risk Stratification and Identification of the Vulnerable Patient | |||||||||||||||
| View the Video Presentation - Bullet Points >> PDF MS-DOC | |||||||||||||||
 |
Patrick Serruys, M.D., Ph.D. – Thorax Center, Erasmus University, Rotterdam, The Netherlands | ||||||||||||||
| Topic: Vulnerable Patients in the Cath Lab; Detect with IVUS+Virtual Histology, Thermography, | |||||||||||||||
| and Palpography, and Treat with Drug-Eluting Stent View the Video Presentation - Bullet Points >> PDF MS-DOC | |||||||||||||||
 |
P.K. Shah, M.D. – Cedars Sinai Medical Center, Los Angles, USA | ||||||||||||||
| Topic: Pan Coronary or Systemic Approach; the Ultimate Therapy for the Vulnerable Patient | |||||||||||||||
| Pictures of the Symposium and Dinner Reception (click for large view) | |||||||||||||||
|
|||||||||||||||||||||||||||||||
 |
 |
 |
 |
||||||||||||||||||||||||||||
 |
 |
 |
|||||||||||||||||||||||||||||
| Discussion Panel | |||||||||
| Topic: How to Implement the VP Pyramid in Preventive Cardiology? Discussing the outline of Part III and IV vulnerable patient consensus statement towards creating a national public screening program for identification of the vulnerable patients. | |||||||||
| The following questions were proposed to the panel for discussion: Questions 1-10 | |||||||||
|
|
|
|
|
|
|
|
||
|
Peter Stone, M.D. |
Pedro Moreno, M.D. |
James H. Chesebro, M.D. | Wolfgang Koenig, M.D., Ph.D. |
Zahi Fayad, Ph.D. |
Patrick Serruys, M.D., Ph.D. |
Morteza Naghavi, M.D. |
||
|
Harvard University, Boston, USA |
Mount Sinai Hospital, New York, USA |
Mayo Clinic, Jacksonville, Florida, USA |
University of Ulm, Ulm, Germany |
Mount Sinai Hospital, New York, USA |
Erasmus University, Rotterdam, The Netherlands |
AEHA, Houston, Texas, USA |
||
|
Conclusion by the Panel Bullet Points >> PDF MS-DOC |
||||||||
|
Dr Stone's Video Presentation - PowerPoint Slides Bullet Points >> PDF MS-DOC Dr Koenig's Video Presentation - PowerPoint Slides Bullet Points >> PDF MS-DOC |
||||||||
